Records containing: Multiple Myeloma and Plasma Cell Neoplasm
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-05-19Proposal for Combining ECOG Myeloma Trial SNP Data
-
CLINICAL_TRIALS study record update · 2017-05-17Screening of Cathepsin G Levels in Multiple Myeloma Patients Receiving Treatment With Thalidomide/Lenalidomide Within the ECOG Trials E1A00 and E4A03
-
CLINICAL_TRIALS study record update · 2017-05-09Substance P Follow-up to a Pilot Study of Aprepitant vs Placebo Combined With Standard Antiemetics for the Control of Nausea and Vomiting During Hematopoietic Cell Transplantation
-
CLINICAL_TRIALS study record update · 2017-05-09Randomized, Double Blinded, Placebo-Controlled Trial of Antibacterial Prophylaxis for the Prevention of Bacterial Infections in the Post-Engraftment Phase After Allogeneic Hematopoeitic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2017-05-08Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-04-17Dapsone Induced Methemoglobinemia in Pediatric Hematologic Malignancy and Aplastic Anemia
-
CLINICAL_TRIALS study record update · 2017-04-11Rasburicase to Prevent Graft -Versus-Host Disease
-
CLINICAL_TRIALS study record update · 2017-03-24Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation as Second Transplantation for Patients With Disease Relapse or Myelodysplasia After Prior Autologous Transplantation
-
CLINICAL_TRIALS study record update · 2017-02-10RC05CB A Pilot, Randomized Comparison of Standard Weekly Epoetin Alfa to Every-3-Week-Epoetin Alfa and Every 3-Week Darbepoetin Alfa
-
CLINICAL_TRIALS study record update · 2017-02-03Probiotic Enteric Regimen For Easing Complications of Transplant : A Pilot Study (PERFECT Trial)
-
CLINICAL_TRIALS study record update · 2016-12-15Phase I/II Trial of Arsenic Trioxide (As2O3) With Ascorbic Acid in the Treatment of Relapsed/Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-12-15Phase I Clinical Trial of Dose Escalated Bortezomib + ATO (Arsenic Trioxide) + Melphalan as a Conditioning Regimen for Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-12-08Randomized Placebo Controlled Double Blind Study of Restasis Versus Placebo in Primary Prevention of Ocular GVHD After Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2016-08-10Risk-Adapted Intravenous Melphalan With Stem Cell Transplant and Adjuvant Bortezomib and Dexamethasone for Recently Diagnosed Untreated Patients With Systemic Light-Chain (AL) Amyloidosis
-
CLINICAL_TRIALS study record update · 2016-07-18A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
-
CLINICAL_TRIALS study record update · 2016-07-13A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
-
CLINICAL_TRIALS study record update · 2016-07-13Phase I/II Trial of Omega-3 Fatty Acids for Cancer Cachexia
-
CLINICAL_TRIALS study record update · 2016-07-07A Phase I/II Study of the Raf Kinase/VEGFR Inhibitor Sorafenib in Combination With the mTOR Inhibitor RAD001 (Everolimus) in Patients With Relapsed Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-07-06Phase III, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Ondansetron in the Control of Chronic Nausea and Vomiting Not Due to Antineoplastic Therapy in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2016-07-04A Phase I Study of Compound 506U78 (NSC #686673) in Patients With Hematologic Malignancies and Renal or Hepatic Impairment
-
CLINICAL_TRIALS study record update · 2016-03-15Phase I/II Trial of Autologous Peripheral Blood Progenitor Cell Transplantation With VELCADE Maintenance as Treatment for Intermediate- and Advanced-Stage Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-02-29A Pilot Study of Double Cord Blood Stem Cell Transplantation in Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2016-01-22Bortezomib + Pegylated Liposomal Doxorubicin (Doxil) + Dexamethasone Followed by Thalidomide + Dexamethasone or Bortezomib + Thalidomide + Dexamethasone for Patients With Symptomatic Untreated High-Risk or Primary Resistant Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-12-14Phase I and Clinical Pharmacokinetic De-Escalation Study of 2'-Deoxycitidine Administered as a Continuous Infusion in Conjunction With a Continuous Infusion of High-Dose ARA-C in Patients With Refractory Acute Myelogenous Leukemia
-
CLINICAL_TRIALS study record update · 2015-11-20Phase II Study of Lenalidomide and Rituximab for Patients With Relapsed and/or Refractory CD20+ Multiple Myeloma